For patients with cataracts and astigmatism, there are toric lenses, which correct for both conditions simultaneously.
Approximately 15% to 29% of cataract patients have more than one diopter of astigmatism which can prevent them from achieving the visual acuity that leads to the spectacle freedom they desire. A new option in astigmatic correction is the Alcon Acrysof Toric IOL which is designed to focus light scattered by corneal astigmatism and minimizes image distortion. Based on the results of the FDA clinical trial, the Acrysof Toric IOL represents an effective option for treating astigmatism.